12:00 PM EDT, 03/31/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Monday acoramidis showed statistically significant improvements in clinical outcomes in both variant and wild-type transthyretin amyloid cardiomyopathy, or ATTR-CM, in a phase 3 trial. The study compared acoramidis with placebo for time to all-cause mortality or first cardiovascular-related hospitalization in both variant and wild-type ATTR-CM, the company...

12:00 PM EDT, 03/31/2025 (MT Newswires) -- Delta Air Lines ( DAL ) shares were lower Monday after the National Transportation Safety Board said it will investigate a close call that took place between a Delta flight and US Air Force jets near Reagan Washington National Airport on Friday, Reuters reported, citing the regulator. The Delta Airbus A319 received a...

12:00 PM EDT, 03/31/2025 (MT Newswires) -- (Updates shares.) Largo (LGO.TO) late on Friday reported that its fourth-quarter loss narrowed even as revenue fell. The company said it lost US$13 million, or US$0.19 per share, narrowing from a loss of US$13.3 million, or US$13.3 million, in the year-prior quarter Revenue came in at US$24.3 million, down from US$44.2 million. The...

12:00 PM EDT, 03/31/2025 (MT Newswires) -- Genmab ( GMAB ) said Monday that the European Commission has granted marketing authorization for Tivdak as a treatment for adult patients with recurrent or metastatic cervical cancer with disease progression on or after systemic therapy. The company said the approval was based on data from a phase 3 trial that met its...